[Federal Register Volume 63, Number 137 (Friday, July 17, 1998)]
[Notices]
[Pages 38671-38674]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-19084]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration
[DEA#167R]


Controlled Substances: Proposed Revised Aggregate Production 
Quotas for 1998

AGENCY: Drug Enforcement Administration (DEA), Justice.

ACTION: Notice of proposed revised 1998 aggregate production quotas.

-----------------------------------------------------------------------

SUMMARY: This notice proposes revised 1998 aggregate production quotas 
for controlled substances in Schedules I and II of the Controlled 
Substances Act (CSA).

DATES: Comments or objections should be received on or before August 
17, 1998.

ADDRESSES: Send comments or objections to the Acting Deputy 
Administrator, Drug Enforcement Administration, Washington, DC 20537, 
Attn.: DEA Federal Register Representative (CCR).

FOR FURTHER INFORMATION CONTACT:
Frank L. Sapienza, Chief, Drug and Chemical Evaluation Section, Drug 
Enforcement Administration, Washington, DC 20537, Telephone: (202) 307-
7183.

SUPPLEMENTARY INFORMATION: Section 306 of the CSA (21 U.S.C. 826) 
requires that the Attorney General establish aggregate production 
quotas for each basic class of controlled substance listed in Schedules 
I and II. This responsibility has been delegated to the Administrator 
of the DEA by Section 0.100 of Title 28 of the Code of Federal 
Regulations. The Administrator, in turn, has redelegated this function 
to the Deputy Administrator of the DEA pursuant to Section 0.104 of 
Title 28 of the Code of Federal Regulations.
    On November 21, 1997, a notice of established initial 1998 
aggregate production quotas for certain controlled substances in 
Schedules I and II was published in the Federal Register (62 FR 62349). 
The notice proposing initial

[[Page 38672]]

1998 aggregate production quotas (62 FR 46373) stipulated that the 
Deputy Administrator of the DEA would adjust the quotas in early 1998 
as provided for in Section 1303 of Title 21 of the Code of Federal 
Regulations.
    The proposed revised 1998 aggregate production quotas represent 
those quantities of controlled substances that may be produced in the 
United States in 1998 to provide adequate supplies of each substance 
for: the estimated medical, scientific, research, and industrial needs 
of the United States; lawful export requirements; and the establishment 
and maintenance of reserve stocks. These quotas do not include imports 
of controlled substances for use in industrial processes.
    The proposed revisions are based on a review of 1997 year-end 
inventories, 1997 disposition data submitted by quota applicants, 
estimates of the medical needs of the United States, and other 
information available to the DEA.
    Therefore, under the authority vested in the Attorney General by 
Section 306 of the CSA of 1970 (21 U.S.C. 826), delegated to the 
Administrator of the DEA by Section 0.100 of Title 28 of the Code of 
Federal Regulations, and redelegated to the Deputy Administrator 
pursuant to Section 0.104 of Title 28 of the Code of Federal 
Regulations, the Acting Deputy Administrator hereby proposes the 
following revised 1998 aggregate production quotas for the following 
controlled substances, expressed in grams of anhydrous acid or base:

------------------------------------------------------------------------
                                            Previously                  
                                            established      Proposed   
               Basic class                 initial 1998    revised 1998 
                                              quotas          quotas    
------------------------------------------------------------------------
Schedule I:                                                             
    2, 5-Dimethoxyamphetamine...........      15,000,100      20,000,100
    2, 5-Dimethoxy-4-ethylamphetamine                                   
     (DOET).............................               2               2
    3-Methylfentanyl....................              14              14
    3-Methylthiofentanyl................               2               2
    3,4-Methylenedioxyamphetamine (MDA).              25              25
    3,4-Methylenedioxy-N-                                               
     ethylamphetamine (MDEA)............              30              30
    3,4-Methylenedioxymethamphetamine                                   
     (MDMA).............................              20              20
    3,4,5-Trimethoxyamphetamine.........               2               2
    4-Bromo-2,5-Dimethoxyamphetamine                                    
     (DOB)..............................               2               2
    4-Bromo-2,5-Dimethoxyphenethylamine                                 
     (2-CB).............................               2               2
    4-Methoxyamphetamine................         100,100         100,100
    4-Methylaminorex....................               2               2
    4-Methyl-2,5-Dimethoxyamphetamine                                   
     (DOM)..............................               2               2
    5-Methoxy-3,4-                                                      
     Methylenedioxyamphetamine..........               2               2
    Acetyl-alpha-methylfentanyl.........               2               2
    Acetylmethadol......................               7               7
    Allylprodine........................               2               2
    Alpha-acetylmethadol................               7               7
    Alpha-ethyltryptamine...............               2               2
    Alphameprodine......................               2               2
    Alpha-methadol......................               2               2
    Alpha-methylfentanyl................               2               2
    Alphaprodine........................               2               2
    Alpha-methylthiofentanyl............               2               2
    Aminorex............................               7               7
    Beta-acetylmethadol.................               2               2
    Beta-hydroxyfentanyl................               2               2
    Beta-hydroxy-3-methylfentanyl.......               2               2
    Beta-methadol.......................               2               2
    Betaprodine.........................               2               2
    Bufotenine..........................               2               2
    Cathinone...........................               9               9
    Codeine-N-oxide.....................               2               2
    Diethyltryptamine...................               2               2
    Difenoxin...........................          16,000          16,000
    Dihydromorphine.....................               7               7
    Dimethyltryptamine..................               2               2
    Ethylamine Analog of PCP............               5               5
    Heroin..............................               2               2
    Hydroxypethidine....................               2               2
    Lysergic acid diethylamide (LSD)....              57              57
    Mescaline...........................               7               7
    Methaqualone........................              17              17
    Methcathione........................              11              11
    Morphine-N-oxide....................               2               2
    N-Ethylamphetamine..................               7               7
    N-Hydroxy-3,4-                                                      
     Methylenedioxyamphetamine..........               4               4
    N,N-Dimethylamphetamine.............               7               7
    Noracymethadol......................               2               2
    Norlevorphanol......................               2               2
    Normethadone........................               7               7
    Normorphine.........................               7               7
    Para-fluorofentanyl.................               2               2
    Pholcodine..........................               2               2
    Psilocin............................               2               2

[[Page 38673]]

                                                                        
    Psilocybin..........................               2               2
    Tetrahydrocannabinols...............          26,000          31,000
    Thiofentanyl........................               2               2
    Trimeperidine.......................               2               2
Schedule II:                                                            
    1-Phenylcyclohexylamine.............              15              15
    1-Piperidinocyclohexanecarbonitrile                                 
     (PCC)..............................              12              12
    Alfentanil..........................           8,100           8,100
    Amobarbital.........................              12              12
    Amphetamine.........................       4,037,000       4,178,000
    Cocaine.............................         550,100         550,100
    Codeine (for sale)..................      62,020,000      62,020,000
    Codeine (for conversion)............      18,460,000      23,906,000
    Desoxyephedrine 1,151,000 grams of                                  
     levodesoxyephedrine for use in a                                   
     non-controlled, non-prescription                                   
     product and 32,000 grams for                                       
     methamphetamine....................       1,332,000       1,183,000
    Dextropropoxyphene..................     109,500,000     109,500,000
    Dihydrocodeine......................         189,000          46,000
    Diphenoxylate.......................       1,600,000       1,600,000
    Ecgonine............................         651,000         651,000
    Ethylmorphine.......................              12              12
    Fentanyl............................         202,000         202,000
    Glutethimide........................               2               2
    Hydrocodone (for sale)..............      13,908,000      16,314,000
    Hydrocodone (for conversion)........       3,000,000       3,000,000
    Hydromorphone.......................         766,000         766,000
    Isomethadone........................              12              12
    Levo-alpha-acetylmethadol (LAAM)....         356,000         356,000
    Levomethorphan......................               2               2
    Levorphanol.........................          15,000          15,000
    Meperidine..........................       9,311,000       9,745,000
    Methadone (for sale)................       3,790,000       5,413,000
    Methadone (for conversion)..........       1,169,000         585,000
    Methadone Intermediate..............       6,777,000       7,488,000
    Methamphetamine (for conversion)....         723,000         723,000
    Methylphenidate.....................      14,442,000      14,442,000
    Morphine (for sale).................      11,535,000      12,034,000
    Morphine (for conversion)...........      75,918,000      75,918,000
    Nabilone............................               2               2
    Noroxymorphone (for sale)...........          25,000          25,000
    Noroxymorphone (for conversion).....       2,117,000       2,177,000
    Opium...............................         615,000         615,000
    Oxycodone (for sale)................       9,032,000       9,451,000
    Oxymorphone.........................         120,000         126,000
    Pentobarbital.......................      16,562,000      16,562,000
    Phencyclidine.......................              60              60
    Phenmetrazine.......................               2               2
    Phenylacetone.......................              10              10
    Secobarbital........................         301,000         397,000
    Sufentanil..........................             700           1,800
    Thebaine............................       9,580,000      13,230,000
------------------------------------------------------------------------

    The Acting Deputy Administrator further proposes that aggregate 
production quotas for all other Schedules I and II controlled 
substances including Secs. 1308.11 and 1308.12 of Title 21 of the Code 
of Federal Regulations remain at zero.
    All interested persons are invited to submit their comments and 
objections in writing regarding this proposal. A person may object to 
or comment on the proposal relating to any of the above-mentioned 
substances without filing comments or objections regarding the others. 
If a person believes that one or more of these issues warrant a 
hearing, the individual should so state and summarize the reasons for 
this belief.
    In the event that comments or objections to this proposal raise one 
or more issues which the Acting Deputy Administrator finds warrant a 
hearing, the Acting Deputy Administrator shall order a public hearing 
by notice in the Federal Register, summarizing the issues to be heard 
and setting the time for the hearing.
    The Office of Management and Budget has determined that notices of 
aggregate production quotas are not subject to centralized review under 
Executive Order 12866. This action has been analyzed in accordance with 
the principles and criteria contained in Executive Order 12612, and it 
has been determined that this matter does not have sufficient 
federalism implications to warrant the preparation of a Federalism 
Assessment.
    The Acting Deputy Administrator hereby certifies that this action 
will have no significant impact upon small entities whose interests 
must be considered under the Regulatory Flexibility Act, 5 U.S.C. 601 
et seq. The establishment of aggregate production quotas for Schedule I 
and II controlled substances is mandated by law and by international 
treaty obligations. Aggregate production quotas apply to

[[Page 38674]]

approximately 200 DEA registered bulk and dosage from manufacturers of 
Schedules I and II controlled substances. The quotas are necessary to 
provide for the estimated medical, scientific, research and industrial 
needs of the United States, for export requirements and the 
establishment and maintenance of reserve stocks. While aggregate 
production quotas are of primary importance to large manufacturers, 
their impact upon small entities is neither negative nor beneficial. 
Accordingly, the Acting Deputy Administrator has determined that this 
action does not require a regulatory flexibility analysis.
Donnie R. Marshall,
Acting Deputy Administrator.
[FR Doc. 98-19084 Filed 7-16-98; 8:45 am]
BILLING CODE 4410-09-M